Bond Biosciences, Inc. — Form D/A
Bond Biosciences, Inc. of Parkville, MO, a company, filed a Form D amendment with the SEC on 2025-12-08. The offering totals $4.5M, of which $4.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2025-12-08
- Form: D/A
- Accession: 0001014108-25-000082
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.1M
- Remaining: $435K
- Investors: 84
- Date of first sale: 2024-08-22
- Revenue range: Decline to Disclose
- SEC file number: 021-523360
Issuer
- Name: Bond Biosciences, Inc.
- CIK: 0001824224
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 170 English Landing Drive SUITE 1201, Parkville, MO, 64152
- Phone: 650-804-2139
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Michael A Beckloff | Director | Parkville, MO |
| Cory A Berkland | Director | Parkville, MO |
| Timothy A Opler | Director | Parkville, MO |
| Michael A Riley | Director | Parkville, MO |
| Cory A Berkland | Executive Officer | Parkville, MO |
| Michael A Riley | Executive Officer | Parkville, MO |
| Cory Berkland | Related Person | Parkville, MO |
| Michael Beckloff | Related Person | Parkville, MO |
| Michael A. Riley | Director | Parkville, MO |
| Michael A. Riley | Executive Officer | Parkville, MO |
| Michael A. Riley | Related Person | Parkville, MO |
| Timothy Opler | Related Person | Parkville, MO |
| Michael A. Beckloff | Director | Parkville, MO |
| Timothy A. Opler | Director | Parkville, MO |
| Cory A. Berkland | Director | Parkville, MO |
| Cory A. Berkland | Executive Officer | Parkville, MO |
Other filings by this issuer (10)
More